Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood

Cytotherapy

Volumn 13, Issue 7, 2011, Pages 848-855

  Spellman, Stephen ^a   Hurley, Carolyn K ^b   Brady, Colleen ^a   Phillips Johnson, Lisa ^j   Chow, Robert ^c   Laughlin, Mary ^d   McMannis, John ^e   Reems, Jo Anna ^f   Regan, Donna ^g   Rubinstein, Pablo ^h   Kurtzberg, Joanne ⁱ  

^a CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c StemCyte   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f PUGET SOUND BLOOD CENTER   (United States)

^g SSM Cardinal Glennon Children's Medical Center   (United States)

^h NEW YORK BLOOD CENTER   (United States)

ⁱ Carolinas Cord Blood Bank   (United States)

^j NATIONAL MARROW DONOR PROGRAM   (United States)

more..

Author keywords

Umbilical cord blood banking; Umbilical cord blood potency assessment; Umbilical cord blood processing; Umbilical cord blood transplantation

Indexed keywords

ARTICLE; ASSAY; CELL THERAPY; EVALUATION; HUMAN; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TECHNIQUE; UMBILICAL CORD BLOOD; VALIDATION PROCESS;

EID: 84860389700     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.571249     Document Type: Article

References (42)

1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilicalcord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-8.
2. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, et al. Successful transplantation of HLAmatched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graftversus- host disease. Blood. 1996;88:795-802.
3. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-66.
4. Laporte JP, Gorin NC, Rubinstein P, Lesage S, Portnoi MF, Barbu V, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med. 1996;335:167-70.
5. Broxmeyer HE. Umbilical cord transplantation: Epilogue. Semin Hematol. 2010;47:97-103.
6. Rocha V, Broxmeyer HE. New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant. 2010;16:S126-32.
7. Rubinstein P. Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution. J Hematother. 1993;2:207-10.
8. Rubinstein P, Rosenfi eld RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81:1679-90.
9. Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein P, et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994;13:135-43.
10. Welte K, Foeken L, Gluckman E, Navarrete C. International exchange of cord blood units: The registry aspects. Bone Marrow Transplant. 2010;45:825-31.
11. Fraser JK, Cairo MS, Wagner EL, McCurdy PR, Baxter-Lowe LA, Carter SL, et al. Cord Blood Transplantation Study (COBLT): Cord blood bank standard operating procedures. J Hematother. 1998;7:521-61.
12. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: A retrospective analysis. Lancet Oncol. 2010;11:653-60.
13. Eapen M, Rubinstei P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet 2007;369:1947-54.
14. Cairo MS, Wagner EL, Fraser J, Cohen G, van de Ven C, Carter SL, et al. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: A Cord Blood Transplantation (COBLT) study report. Transfusion. 2005;45:856-66.
15. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purifi ed from human cord blood: Preliminary report. Leukemia. 2007; 21:297-303.
16. Zuba-Surma EK, Klich I, Greco N, Laughlin MJ, Ratajczak J, Ratajczak MZ. Optimization of isolation and further characterization of umbilical-cord-blood- derived very small embryonic/ epiblast-like stem cells (VSELs). Eur J Haematol. 2010;84: 34-46.
17. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-effi ciency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA. 2003;100:645-50.
18. Center for Biologics Evaluation and Research, Rockville, MD. Minimally Manipulated, Unrelated Allogeneic Placental/ Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specifi ed Indications. FDA Guidance for Industry. US Department of Health and Human Services, Food and Drug Administration; 2009. http://www.fda.gov/downloads/ BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/ Guidances/Blood/UCM187146.pdf. Accessed date: 14 April 2010.
19. NetCord-FACT, Omaha, NE. International Standards for Cord Blood Collection, Banking, and Release for Administration. 4th ed. NetCord-FACT; 2010. http://www.factwebsite. org/uploadedFiles/News/4th-Edition-Cord-Blood- Standards-4.0.pdf. Accessed date: 14 April 2010.
20. Goodwin HS, Grunzinger LM, Regan DM, McCormick KA, Johnson CE, Oliver DA, et al. Long term cryostorage of UC blood units: Ability of the integral segment to confi rm both identity and hematopoietic potential. Cytotherapy. 2003;5:80-6.
21. Rodriguez L, Garcia J, Querol S. Predictive utility of the attached segment in the quality control of a cord blood graft. Biol Blood Marrow Transplant. 2005;11:247-51.
22. Stevens CE, Gladstone J, Taylor PE, Scaradavou A, Migliaccio AR, Visser J, et al. Placental/umbilical cord blood for unrelateddonor bone marrow reconstitution: Relevance of nucleated red blood cells. Blood. 2002;100:2662-4.
23. Rubinstein DB, Leblanc P, Wright DG, Guillaume T, Strotchevoi A, Boosalis M. Anti-CD34+ Fabs generated against hematopoietic stem cells in HIV-derived combinatorial immunoglobulin library suggest antigen-selected autoantibodies. Mol Immunol. 1998;35:955-64.
24. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717-22.
25. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: Infl uence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979-89.
26. Scaradavou A, Smith KM, Hawke R, Schaible A, Abboud M, Kernan NA, et al. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant. 2010; 16:500-8.
27. Brown B. Hematology: Principles and Procedures. 6th ed. Philadelphia: Lea & Febiger; 2006.
28. Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M, et al. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion. 2006;46:507-15.
29. International Conference on Harmonisation. Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text And Methodology Q2(R1) Current Step 4 version, Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005), Ness Ziona, Israel. http://www.bioforum. org.il/Uploads/Editor/karen/q2-r1- step4.pdf. Accessed date: 14 April 2010.
30. Center for Biologics Evaluation and Research, Rockville, MD. Potency Tests for Cellular and Gene Therapy Products. FDA Draft Guidance for Industry. US Department of Health and Human Services; 2008. http://www.fda.gov/downloads/ BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/ Guidances/CellularandGeneTherapy/ucm078687.pdf. Accessed date: 14 April 2010.
31. Lasky LC, Lane TA, Miller JP, Lindgren B, Patterson HA, Haley NR, et al. In utero or ex utero cord blood collection: Which is better? Transfusion. 2002;42:1261-7.
32. Jaing TH, Chen SH, Tsai MH, Yang CP, Hung IJ, Tsay PK. Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: A single institution's experience with 45 patients. Biol Blood Marrow Transplant. 2010;16:102-7.
33. Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing TH, Graham ML, et al. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced. Biol Blood Marrow Transplant. 2007;13: 1346-57.
34. American Association of Blood Banks. Standards for Blood Banks and Transfusion Services, Bethesda, MD. 26th ed. AABB Standard: 5.18.1.2.4. American Association of Blood Banks; 2009.
35. NetCord-FACT, Omaha, NE. International Standards for Cord Blood Collection, Banking, and Release for Administration. 4th ed. FACT standard D7.5.1. NetCord-FACT; 2010.
36. Takahashi TA, Rebulla P, Armitage S, van Beckhoven J, Eichler H, Kekomaki R, et al. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: Infl uence on cell recoveries. Cytotherapy. 2006;8:254-64.
37. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy. 2001;3:377-86.
38. Chow R, Law P, Wang B, Rosenthal J, Nademanee A, Karanes C, et al. Negative impact of post-thaw washing on the overall survival (OS) and disease free survival (DFS) of patients receiving plasma depleted (PD) cord blood (CB) transplantation. Biol Blood Marrow Transplant. 2009;15(Suppl 2) Abstract no: O-39:17.
39. Regan DM, Wofford JD, Wall DA. Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion. 2010;50:2670-5.
40. Barker JN, Abboud M, Rice RD, Hawke R, Schaible A, Heller G, et al. A ' no-wash'albumin-dextran dilution strategy for cord blood unit thaw: High rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant. 2009;15:1596-602.
41. Cord Blood Transplantation Study (COBLT), Rockville, MD. Cord Blood Bank Standard Operating Procedures. Carolinas Cord Blood Bank-Duke University & University of California- Los Angeles Cord Blood Bank. https://web.emmes.com/ study/ cord/sop.htm.
42. Rubinstein P, Dobrila L, Rosenfi eld RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92: 10119-22.